GSK plc GLAXF
OTC PK
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 5.87% | 9.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.87% | 9.83% | |||
| Cost of Revenue | 8.30% | 10.23% | |||
| Gross Profit | 5.08% | 9.70% | |||
| SG&A Expenses | -0.64% | 4.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 91.65% | 66.95% | |||
| Total Operating Expenses | 8.70% | 19.03% | |||
| Operating Income | -0.44% | -6.34% | |||
| Income Before Tax | 447.59% | -83.55% | |||
| Income Tax Expenses | 216.79% | -165.01% | |||
| Earnings from Continuing Operations | 208.51% | -70.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -35.84% | -15.27% | |||
| Net Income | 255.35% | -75.05% | |||
| EBIT | -0.44% | -6.34% | |||
| EBITDA | 17.98% | -12.88% | |||
| EPS Basic | 255.74% | -74.99% | |||
| Normalized Basic EPS | -6.21% | -7.02% | |||
| EPS Diluted | 254.94% | -74.98% | |||
| Normalized Diluted EPS | -6.57% | -6.97% | |||
| Average Basic Shares Outstanding | -0.12% | -0.22% | |||
| Average Diluted Shares Outstanding | 0.27% | -0.29% | |||
| Dividend Per Share | 0.18% | -0.35% | |||
| Payout Ratio | -0.74% | 3.51% | |||